Inactive Instrument

Calendar Allarity Therapeutics, Inc. Nasdaq Stockholm

Equities

ALLR

US0167441049

Chart calendar Allarity Therapeutics, Inc.

85ec.w9KExhMhVPuIbBBHEWHTajgyqI9-pnCKa0JuFvgwvm4.sYvW915tGKO8IXceYyeZHQELyuc_4ynTPC8xY85U2Q2LjdeiVXgtnuNBSQ~7f72b68d10c0aec6a50691ba12daa825

Upcoming events on Allarity Therapeutics, Inc.

2024-05-23 Q1 2024 Earnings Release (Projected)
2024-10-07 Q2 2024 Earnings Release (Projected)
2024-11-11 Q3 2024 Earnings Release (Projected)
2025-05-18 Q4 2024 Earnings Release (Projected)

Past events on Allarity Therapeutics, Inc.

2024-03-08 07:15 am Q4 2023 Earnings Release
2024-02-28 Biomarkers Congress
2023-11-13 Biomarkers Europe Congress
2023-10-18 ThinkEquity Conference
2023-06-23 01:00 pm Extraordinary Shareholders Meeting
2023-06-03 09:00 am American Society of Clinical Oncology Conference - Abstract # 3130
2023-03-19 Extraordinary Shareholders Meeting
2023-02-03 01:00 pm Annual General Meeting
2022-12-02 01:00 pm Annual General Meeting
2022-11-15 04:01 pm Q3 2022 Earnings Release
2022-10-11 04:05 pm Interim 2022 Earnings Release
2022-09-29 03:00 pm Ladenburg Thalmann Healthcare Conference
2022-05-27 05:37 pm Q1 2022 Earnings Release
2022-05-16 07:40 pm FY 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,12
0,54
-78.12%
0,00
0,15
-
0,00


0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
-9,81
-17,2
42.98%
-9,31
-8,96
-3.88%
0,00


0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-21,8
-17,0
-28.61%
-9,47
-9,13
-3.68%
0,00


-32,7
-31,5
-3.64%
-17,1
-16,7
-2.5%

-23,6

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-25,8
-17,3
-49.27%
-9,33
-7,71
-21.03%
0,00


-17,6
-20,0
12.17%
-11,8
-14,5
18.58%

-16,5

Net income
Million USD
Released
Forecast
Spread
-20,4
-15,4
-32.08%
-7,53
-6,85
-9.81%
-26,6


-21,1
-20,4
-3.35%
-20,4
-14,5
-40.66%

-16,5

EPS
USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00


-3 094
-3 038
-1.84%
-10,3
-206
95.02%

-1,43

Announcement Date31/03/2031/03/2117/05/2213/03/2308/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-4,30
-5,35
19.51%
-4,33
-5,61
22.86%
-4,56
-3,30
-38.43%
-4,97
-4,33
-14.67%
-3,66
-3,63
-0.94%
-4,16
-3,59
-15.9%
-4,43
-3,51
-25.95%
-4,88
-4,47
-9.15%

-4,94


-5,92


-6,22


-6,53

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-4,31
-5,35
19.42%
-4,65
-5,61
17.09%
-5,03
-2,89
-74.18%
-3,14
-4,38
28.24%
-3,35
-3,63
7.53%
-2,38
-3,59
33.63%
-4,45
-3,51
-26.55%
-1,64
-4,34
62.19%

-3,16


-3,10


-5,21


-5,02

Net income
Million USD
Released
Forecast
Spread
-4,65
-5,35
12.97%
-4,66
-5,61
17.02%
-6,68
-2,89
-131.33%
-3,10
-4,38
29.13%
-3,36
-3,63
7.42%
-9,79
-3,59
-172.89%
-5,55
-3,51
-58%
-1,72
-4,34
60.28%

-3,16


-3,10


-5,21


-5,02

EPS
USD
Released
Forecast
Spread
-784
-924
15.15%
-728
-966
24.64%
-952
-357
-166.67%
-322
-588
45.24%
-177
-315
43.78%
-26,3
-11,2
-134.85%
-2,24
-8,17
72.58%

-0,25


-0,53


-0,28


-0,32


-0,31

Announcement Date27/05/2222/08/2214/11/2213/03/2311/05/2314/08/2314/11/2308/03/24----